AAVCAGsCD59

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AAVCAGsCD59, covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: AAVCAGsCD59 for the Treatment of Wet AMD [Phase 1]